[Heart failure in dilated cardiomyopathy and coronary heart disease. The contribution of biochemical parameters to assessing the prognosis].
Regitz
V
V
Klinik für Innere Medizin/Kardiologie, Deutsches Herzzentrum Berlin.
Shug
A L
AL
Schüler
S
S
Yankah
C
C
Hetzer
R
R
Fleck
E
E
D002311:Cardiomyopathy, Dilated / Q000150:complications / Q000378:metabolism* / Q000401:mortality; D002331:Carnitine / Q000172:deficiency / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism; D003327:Coronary Disease / Q000150:complications / Q000378:metabolism* / Q000401:mortality; D005947:Glucose / Q000378:metabolism; D006333:Heart Failure / Q000209:etiology / Q000378:metabolism* / Q000401:mortality; D006801:Humans; D009206:Myocardium / Q000378:metabolism; D010710:Phosphates / Q000378:metabolism; D011379:Prognosis
D002395:Catecholamines; D010710:Phosphates; D005947:Glucose; D002331:Carnitine
Herzinsuffizienz bei dilatativer Kardiomyopathie und koronarer Herzkrankheit. Beitrag biochemischer Parameter zur Beurteilung der Prognose.